Sumeet Bhatia

No bio available.

Financial relationships

  • Attribution:
    Self
    Type of financial relationship:
    Stock
    Ineligible company:
    Iovance
    Topic:
    melanoma
    Date added:
    09/15/2024
    Date updated:
    09/15/2024
    Relationship end date:
    09/01/2026
  • Attribution:
    Self
    Type of financial relationship:
    Stock
    Ineligible company:
    syndax
    Topic:
    leukemia
    Date added:
    09/15/2024
    Date updated:
    09/15/2024
    Relationship end date:
    09/01/2026
  • Attribution:
    Self
    Type of financial relationship:
    Stock
    Ineligible company:
    Jansen
    Topic:
    myeloma,leukemia
    Date added:
    09/15/2024
    Date updated:
    09/15/2024
    Relationship end date:
    09/25/2025
  • Attribution:
    Self
    Type of financial relationship:
    Stock
    Ineligible company:
    Lilly
    Topic:
    leukemia
    Date added:
    09/15/2024
    Date updated:
    09/15/2024
    Relationship end date:
    09/26/2026
  • Attribution:
    Self
    Type of financial relationship:
    Stock
    Ineligible company:
    Genmab
    Topic:
    leukemia
    Date added:
    09/15/2024
    Date updated:
    09/15/2024
    Relationship end date:
    09/28/2026
  • Attribution:
    Self
    Type of financial relationship:
    Stock
    Ineligible company:
    Biontech
    Topic:
    multiple
    Date added:
    09/15/2024
    Date updated:
    09/15/2024
    Relationship end date:
    09/28/2026
  • Attribution:
    Self
    Type of financial relationship:
    Stock
    Ineligible company:
    Abbvie
    Topic:
    multiple
    Date added:
    09/15/2024
    Date updated:
    09/15/2024
    Relationship end date:
    09/30/2026
  • Attribution:
    Self
    Type of financial relationship:
    Stock
    Ineligible company:
    Allogene
    Topic:
    multiple
    Date added:
    09/15/2024
    Date updated:
    09/15/2024
    Relationship end date:
    09/30/2027
  • Attribution:
    Self
    Type of financial relationship:
    Stock
    Ineligible company:
    Zymeworks
    Topic:
    solid tumors
    Date added:
    09/15/2024
    Date updated:
    09/15/2024
    Relationship end date:
    09/04/2024
  • Attribution:
    Self
    Type of financial relationship:
    Stock
    Ineligible company:
    Immunocore
    Topic:
    melanoma
    Date added:
    09/15/2024
    Date updated:
    09/15/2024
    Relationship end date:
    09/24/2026

Pages

Return to 2024 Summit on Hematological Cancers